ArticleFrontiers in bioengineering and biotechnology2022

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment.

Mengting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.